UMB298 is a potent and selective small-molecule inhibitor targeting the CBP/P300 bromodomains. It exhibits significantly lower activity against BRD4 (IC50 = 5193 nM). This compound is a valuable chemical probe for epigenetic research, facilitating the study of CBP/P300 function in transcriptional regulation in both cellular and biochemical assays.